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Abstract  
AIM: Patient-prosthesis mismatch (PPM) is a common occurrence in aortic valve surgery. Even the 
discussions about the impact of this phenomenon on the results of aortic valve surgery, the 
management of this problem remain one of the main topics in this kind of surgery. One of the ways 
of a solution is aortic annulus enlargement. The main topic of this study is to evaluate the early and 
longterm results of this technique in our country.  
METHODS: During the period January 2010 –January 2015, 641 patients performed aortic valve 
surgery. In ten patients we performed aortic annulus enlargement according to Manouguian 
technique to avoid severe patient-prothesis mismatch.Operative mortality and perioperative 
complications (low cardiac output, pulmonary complications, etc..) were considered the indicators of 
the early results. Survival, clinical presentation according to NYHA, quality of life were the indicators 
to evaluate long-term results. Preoperative and postoperative echocardiographic data were also 
used to evaluate our results. We collected the data from hospital registrations and periodical clinical 
visit and echographic examination after hospital discharge. 
 
RESULTS: In our group, 6 of 10 patients were diagnosed with stenotic aortic valve, two patients 
had aortic valve regurgitation and two mixed valve pathology. Four patients had concomitant 
cardiac surgery procedure, mitral or CABG. In all cases, aortic valve pathology was the primary 
diagnose.In the preoperative echocardiographic examination mean transvalvular gradient was 54.3 
± 6.42.We had no death during early or late postoperative period. Only one patient had pulmonary 
complications and long time of respiratory assistance because of his pulmonary pathology.The 
same patient had low cardiac output and wound infection. Early after surgery mean transprostethic 
gradient was 16.2 ± 3.44 and late postoperative was 15.9 ± 4.3. No patient had the severe patient-
prothesis mismatch. Mean follow-up was 49 ± 20.26 months. During follow-up, we had no death, 
and all patients had very good quality of life.
 
CONCLUSIONS: Aortic valve annulus enlargement can be used with very good early and late 
results with the final goal to increase the potential benefit of the patient from surgery of aortic valve. 
 
 
 
Introduction 
 
 Prosthesis - patient mismatch is the 
common occurrence in aortic valve surgery. Despite 
the discussions about the impact of this phenomenon 
on the results of aortic valve surgery, the 
management of this issue remains one of the major 
objectives of this type of surgery. One way of 
solutions for this phenomenon is the use of aortic 
annulus enlargement technique.  
 Objectives of this work are to present the 
early and late results of this technique in our 
experience. 
Patients and Methods 
 
During the period January 2010 - January 
2015, 641 patients performed aortic valve surgery 
isolated or combined with other surgical procedures. 
We realised aortic annulus enlargement in 10 patients 
according to Manouguian technique [1] to avoid the 
occurrence of patient- prosthesis mismatch. The 
mean age of the group was 49 ± 17.7. There were 
three males and seven females in all cases; the 
primary pathology was aortic valve disease. 
Indications for operation are made according to the 
European or American associations of Cardiology 
guidelines [2, 3]. The main diagnostic tool examination 
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was echocardiography. Six patients were with aortic 
valve stenosis, two with aortic valve regurgitation and 
two others with mixed pathology.  
Table 1:  General data 
General Data 
 
Nr Patients 10 
Mean Age 
 
49 ± 17.7 
Gender 
 
3M/7F 
BSA 
 
1.69 ± 0.14 
Pathology AVS 6 Pt 
  
AVR 2 Pt 
  
Mixed 2 Pt 
CABG 
 
3 Pt 
Mitral 
 
1 Pt 
Esc Stand 4.7 ± 1.36 
Esc Log 
 
4.35 ± 1.35 
  
The aortic annulus size ranged from 18-23 
mm with an average of 20.1 ± average 1.42. The 
thickness of left ventricle septum and posterior wall 
were respectively 13.1 ± 0.9 and 12.2 ± 1.24 mm. 
Body surface of patients ranged from 1.5-2m^2 (mean 
1.69 ± 12.14), hospital mortality and perioperative 
complications (low cardiac debit, pulmonary 
complications, renal complications, reexploration for 
bleeding, ventricular arrhythmias, conductions 
disturbances, wound infections) are considered 
indicators of early results evaluation.  
Table 2: Echocardiographic data 
 Echocardiografic Data 
 
 EF% 
 
63.3 ± 3.53 
 Annulus 
 
20.1 ± 1.42 
 ThPW 
 
12.2 ± 1.24 
 ThS 
 
13.1 ± 0.9 
 EDD 
 
52.7 ± 5.7 
 ESD 
 
30.8 ± 3.2 
 Mean Grad 54.3 ± 6.4 
     EF-ejection fraction, ThPW-thickness posterior wall, Ths-the knees septum, EDD-end 
diastolic diameter, ESD-end systolic diameter, Grd-gradient. BSA-body surface area, Esc 
stand –Log-euro store standard and logistic. 
 
The mean follow-up time was 49 ± 20.26 
months. Survival, clinical condition according to NYHA 
class and quality of life were indicators of long-term 
results evaluation. Follow-up was complete. The data 
were collected from hospital records and periodic 
clinical and laboratory examinations after hospital 
discharge. The data are presented in average value 
and standard deviation (Table 1 and Table 2). 
 
Figure 1: Schematic figure of Manouguian technique 
Interventions were performed through the 
median sternotomy with standard cardiopulmonary 
bypass and systemic hypothermia to 32
0
C. An oblique 
osteotomy was performed, and myocardial protection 
was provided by intermittent antegrade crystalloid 
(first dose), and cold blood cardioplegia delivered 
directly into the coronary ostium. After excision of the 
native aortic valve and meticulous decalcification, the 
aortic annulus was sized. The decision to enlarge the 
aortic was taken when the 19-mm sizer could not be 
implanted and according to the body surface area of 
the patient and the type of prosthesis available. Aortic 
Annulus enlargement was done using the 
Manouguian technique. Aortotomy was extended 
through annulus into the fibrous trigone between the 
noncoronary cusp and the left coronary cusp to the 
subaortic curtain and anterior mitral valve leaflet.This 
defect was closed using a synthetic Teflon patch.
 
 
 
Patch from outside 
 
Patch from inside 
 
Figure 2: Photos during intervention 
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Results 
 
 We had no hospital death in our series. One 
patient had post-operative pulmonary complications 
because of his pulmonary preoperative illness. The 
same patient had low cardiac output and wound 
infection. All these complications were treated with 
intensive therapy.
 
 Operative and postoperative data are 
presented in Table 3. Average prosthesis number 
used was 20.8 ± 1.75 and ranged from 19-25. The 
types of the prosthesis implanted were SJM: one SJM 
Regent, one biological prosthesis SJM Epic Supra 
and others SJM Standard. The average trans-
prosthetic gradient was 16.2 ± 3.44 and ranged from 
12-25 mmHg. Indexed effective prosthesis surface 
mean value was 0.86 ± 0.14 cm^2/m^2. Based on the 
reference values of effective orifice area we used, no 
patient come out with severe MPP. 
 We see that there were long intervention 
times. This fact can be explained considering that four 
patients (40 % of the group) have undergone 
simultaneous surgical procedures (three cases CABG 
and one case mitral valve repair). Long respiratory 
assistance and intensive therapy stay time-related to 
the situation in which one patient (10 % of the group) 
is treated for a long time in intensive care unit.
 
Table 3: Operative and postoperative data 
 Operative and postoperative data 
CPBt 150.3± 19.7 
XCt 118.2 ± 15.6 
Prot Nr 20.8 ± 1.75 
Resp As time 25 ± 21.4 
ICU time 102.3 ± 94.7 
Hosp time 13.3 ± 7.08 
Prot Grad 16.2 ± 3.44 
EOAi 0.86 ± 0.14 
CPBt = cardiopulmonary bypass time, XCt = cross-clamp time, Prot nr = prothesis number, 
Resp As time = respiratory assistance time, ICU = intensive care unit, hosp = hospital, Prot 
grad = prosthesis gradient, EOAi = effective orifice area indexed. 
 
 All patients survived during a follow-up 
period. They were in NYHA 1 clinical status four 
patients and asymptomatic the other part. The quality 
of life was very good. One patient had gastrointestinal 
bleeding from anticoagulation two years after the 
intervention. 
 
 
 
Discussion 
 
 Patient-prosthesis mismatch is a common 
phenomenon in the aortic valve surgery. This problem 
that has been presented by Rahimtola since 1978 [4] 
is present also in our series of patients who has 
performed aortic valve surgery. The incidence 
resulted from 10.3 % and 67.8 % respectively for 
severe PPM and moderate PPM [5]. To achieve the 
maximum of patient benefit from the replacement of 
the aortic valve, to avoid the phenomenon of patient -
prosthesis mismatch, we have followed the strategy of 
aortic valve annulus enlargement according to 
Manouguian [1]. The technique is an additional 
surgical procedure in standard aortic valve, therefore, 
increases the complexity of the surgery. This is the 
reason why the discussion about the impact of this 
procedure in the early and late results of aortic valve 
surgery is still opened. 
 Annulus aortic valve enlargement is a safe 
procedure. In a study where 172 patients have 
performed aortic annulus enlargement Kulik et al. 
report mortality 7% while in 540 patients who realised 
standard aortic valve replacement mortality resulted 
from 6.5%. Major post-operative complications were 
no differences between groups with or without 
annulus enlargement. The PPM incidence and trans-
prosthetic gradients were significant lower in the 
group with AAE (p < 0.01, p < 0.0001) [6]. Hospital 
mortality in groups of patients who realised aortic 
valve replacement with annulus enlargement varies 
0.9-7%. Perioperative morbidity has no significant 
differences compared with standard valve 
replacement surgery. These results are presented in 
some separated studies. All studies refer that the 
occurrence of PPM is always minimised [6-9].  
 We see that the early results of aortic valve 
surgery results referred are not influenced by the 
additional annulus enlargement.This procedure is 
related strongly to the benefit of diminution of patient – 
prosthesis mismatch incidence and lower trans-
prosthetic gradients. In our group of patients, we had 
no hospital deaths. The times of intervention, 
intensive therapy stay and respiratory assistance 
resulted longer in comparison with a series of our 
patients with isolated standard aortic valve surgery [5]. 
These results can be explained by considering the 
small group of patients (10 patients) among which four 
patients (40%) have performed simultaneous 
procedures and one patient who had a preoperative 
pulmonary disease for which was treated for a long 
time in intensive therapy unit. No patient was in 
severe PPM postoperatively. 
 There are authors by analysing their results 
refer that small aortic valve prosthesis is not an 
independent risk factor for the early results and find 
aortic annulus enlargement among strong predictors 
of hospital mortality. Aortic annulus enlargement 
should be used carefully [10]. 
 Urso et al. in a review made regarding the 
impact of PPM in the early and intermediate the 
results aortic valve surgery conclude that severe PPM 
is an independent risk factor for early and 
intermediate outcomes. This phenomenon should be 
avoided. Moderate PPM has the impact on patients 
with severe impairment function of a left ventricle.PPM 
should be managed because has direct negative 
impact on early results of aortic valve surgery [11]. 
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 Kitamura et al. studied the impact of AAE 
on long-term results.Ten years survival was 85.7 % in 
the group that have performed AAE and 62.7 % in the 
group with small prosthetic but have not realised at 
the same time AAE. The independence from events 
related to the prosthesis referred respectively 81% 
and 58.8%. The difference of survival is not 
statistically significant, but the difference in absolute 
value is clear while for events related to the prosthesis 
is the very important difference [9].
 
 In the contingent of patients named LGAS 
(low gradient aortic stenosis), PPM should avoid. PPM 
affects importantly adversely long-term results. In this 
special group of patients, PPM is related strongly to 
lower survival and independence from heart failure 
[12].
 
 In this context in a study where were 
involved 805 patients and from them 548 patients had 
VM low function with (EF < 50%) Kulik et al refer that 
the patients with low EF and with PPM survival and 
independence from clinical death from heart failure is 
importantly lower in the long term in comparison with 
patients without PPM (p = 0.03, p = 0.009) [13]. 
 The last two works take as point reference 
moderate PPM (SEPi ≤ 0.85 cm^2/m^2). To avoid the 
negative consequences of MPP in aortic valve surgery 
results we should include the avoidance strategy of 
this phenomenon at the time of surgical procedure. 
 There are studies that denied negative 
effects of PPM in the early or late results of aortic 
valve surgery [14, 15], but in a meta-analyses where 
are selected 34 works and involved 27,186 patients to 
give response to the question of how long-term results 
are influenced by PPM realizing AVR was concluded 
that PPM is associated with increased cardiac or other 
reasons mortality in long term. The efforts to prevent 
PPM should be highlighted and disseminated to 
improve the results of aortic valve surgery [16].
 
 In conclusion, aortic valve annulus 
enlargement can be used with very good early and 
late results with the final goal to increase the potential 
benefit of the patient from surgery of aortic valve. 
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